# Phase 11 Audit — Verification Correction
Date: 2026-08-11
Status: CORRECTED / VERIFIED

## Correction 1 — regression count
The previously stated Phase 11 audit capability/release/documentation regression count of **73/73** was not a valid named audit bucket.

The reproducible regression surface for this audit is:

- Phase 5c validation queue
- Phase 5d CBC evidence/single-reviewer checks
- Phase 5e external-review readiness
- Phase 5f commercial-review readiness
- Phase 5g release documentation

Exact test-file set:
- tests/test_phase5c_validation_queue.py
- tests/test_phase5d_cbc01_evidence_packet.py
- tests/test_phase5d_cbc02_evidence_packet.py
- tests/test_phase5d_cbc06_evidence_packet.py
- tests/test_phase5d_cbc07_evidence_packet.py
- tests/test_phase5d_cbc08_evidence_packet.py
- tests/test_phase5d_cbc09_evidence_packet.py
- tests/test_phase5d_cbc10_evidence_packet.py
- tests/test_phase5d_single_reviewer_clinical_review.py
- tests/test_phase5e_external_review_readiness.py
- tests/test_phase5f_commercial_review_readiness.py
- tests/test_phase5g_release_documentation.py

Fresh result: **68 passed, 0 failed**.

The earlier 73 number resulted from an ad hoc broader selection that also included five Phase 5b/positioning tests. It was therefore not a defensible Phase 11 audit regression count.

## Correction 2 — stale PEEP capability row
The historical row:
`PEEP-to-ECMO drainage coupling via transmural preload`
still incorrectly described the mechanism as blocked even though Phase 10a implemented it.

All three capability-matrix mirrors now mark that row implemented/integrated/learner-operable and explicitly identify it as a **SUPERSEDED DUPLICATE** retained only for row-history continuity. The authoritative status remains the CBC07 / Phase 10a row immediately above it.

Capability-matrix row count remains **101**.

## Unchanged Phase 11 conclusion
The Phase 11 feasibility/ownership decision remains **STOP / RESCOPE**. No `src/` physiology code and no tests were changed by the Phase 11 audit/correction. The topology-dependent ELSO rationale and recommendation for a topology-aware regional-perfusion foundation are unchanged.
